Ligand validation:2I3G

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2I3G_BTB_A_600	77%	67%	0.107	0.947	0.54	0.71	-	-	0	0	100%	1
2I3G_BTB_B_700	40%	66%	0.153	0.865	0.61	0.69	-	-	0	0	100%	1
7NNR_BTB_A_402	73%	76%	0.111	0.938	0.47	0.47	-	-	0	0	100%	1
2I3A_BTB_D_1700	61%	45%	0.135	0.923	1.43	0.73	2	-	0	0	100%	1
7NNQ_BTB_B_402	6%	92%	0.35	0.781	0.24	0.27	-	-	0	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
8Z2G_BTB_A_402	99%	57%	0.046	0.976	0.81	0.83	-	-	0	0	100%	1
5O59_BTB_A_605	99%	76%	0.057	0.987	0.52	0.44	-	-	2	0	100%	1
2W1S_BTB_A_1948	99%	62%	0.043	0.972	0.78	0.67	-	-	0	0	100%	1
2OB3_BTB_A_906	98%	13%	0.06	0.986	2.82	1.16	4	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.